Market Tracker

10/20 5:16pm ET

Sarepta Therapeutics Inc (NASDAQ:SRPT)

51.94
Delayed Data
As of Oct 20
 +1.22 / +2.41%
Today’s Change
26.26
Today|||52-Week Range
52.67
+89.35%
Year-to-Date
Market Still Lacks Ability to Find Volatility
Oct 20 / TheStreet.com - Paid Partner Content
Keep a Close Watch on What the Dip Buyers Do
Oct 16 / TheStreet.com - Paid Partner Content
I'm Rooting for an Ugly Close but Not Holding My Breath
Oct 18 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close50.72
Today’s open50.80
Day’s range50.38 - 52.11
Volume1,669,506
Average volume (3 months)2,420,251
Market cap$3.3B
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-5.58%
Earnings growth (this year)+79.02%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)+332.64%
P/E ratioNM
Price/Sales246.40
Price/Book8.45

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...+3.31+4.31%
LOXOLoxo Oncology Inc+1.59+1.87%
RAREUltragenyx Pharmaceu...0.000.00%
IRWDIronwood Pharmaceuti...+0.04+0.27%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.87
Annual revenue (last year)$5.4M
Annual profit (last year)-$267.3M
Net profit margin-4,930.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas S. Ingram
Executive VP, Chief Financial &
Business Officer
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts